A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

ישראלפעיל (ללא גיוס)PHASE3

מצבים רפואיים

Chronic Rhinosinusitis With Nasal Polyps

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of Southern California (USC) / Keck Medicine of USC- Site Number : 8400037, Arcadia, California, United States

  • Sensa Health- Site Number : 8400038, Los Angeles, California, United States

  • Newport Native MD- Site Number : 8400031, Newport Beach, California, United States

  • Sacramento Ear Nose & Throat - Roseville- Site Number : 8400064, Roseville, California, United States

  • Breathe Clear Institute of Sinus and Allergy Relief- Site Number : 8400040, Torrance, California, United States

  • Orso Health - Torrance - Hawthorne Boulevard- Site Number : 8400035, Torrance, California, United States

  • Advanced Research Associates (ARA) Professionals- Site Number : 8400011, Miami, Florida, United States

  • Paradisus Med Research - Miami- Site Number : 8400009, Miami, Florida, United States

  • Orlando ENT Associates - Orlando- Site Number : 8400008, Orlando, Florida, United States

  • Emory University School of Medicine- Grady Campus- Site Number : 8400047, Atlanta, Georgia, United States

  • Treasure Valley Medical Research- Site Number : 8400063, Boise, Idaho, United States

  • University of Chicago Medical Center- Site Number : 8400018, Chicago, Illinois, United States

  • Deaconess Clinic Allergy East- Site Number : 8400056, Evansville, Indiana, United States

  • SSM Health Saint Louis University Hospital- Site Number : 8400005, St Louis, Missouri, United States

  • Northwell Health Physician Partners Rheumatology at Great Neck- Site Number : 8400028, Great Neck, New York, United States

  • Essential Medical Research- Site Number : 8400066, Tulsa, Oklahoma, United States

  • TEN20 Clinical Research - Dallas- Site Number : 8400015, Dallas, Texas, United States

  • Houston Methodist Hospital- Site Number : 8400054, Houston, Texas, United States

  • ENT Associates of Texas - McKinne- Site Number : 8400062, McKinney, Texas, United States

  • Alamo ENT Associates- Site Number : 8400065, San Antonio, Texas, United States

  • Eastern Virginia Medical School (EVMS) Medical Group- Site Number : 8400046, Norfolk, Virginia, United States

  • Investigational Site Number : 0320002, La Plata, Buenos Aires, Argentina

  • Investigational Site Number : 0320004, Rosario, Santa Fe Province, Argentina

  • Investigational Site Number : 0320001, Buenos Aires, Argentina

  • Investigational Site Number : 0320005, Buenos Aires, Argentina

  • Investigational Site Number : 0320003, Mendoza, Argentina

  • Investigational Site Number : 0400005, Graz, Austria

  • Investigational Site Number : 0400002, Linz, Austria

  • Investigational Site Number : 0400001, Vienna, Austria

  • Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto- Site Number : 0760002, Ribeirão Preto, São Paulo, Brazil

  • Centro Internacional de Pesquisa Clínica (CIPES)- Site Number : 0760005, São José dos Campos, São Paulo, Brazil

  • Hospital Israelita Albert Einstein- Site Number : 0760001, São Paulo, Brazil

  • Investigational Site Number : 1240005, London, Ontario, Canada

  • Investigational Site Number : 1240002, Montreal, Quebec, Canada

  • Investigational Site Number : 1240001, Québec, Quebec, Canada

  • Investigational Site Number : 1520006, Valdivia, Los Ríos Region, Chile

  • Investigational Site Number : 1520003, Talca, Maule Region, Chile

  • Investigational Site Number : 1520004, Lo Barnechea, Reg Metropolitana de Santiago, Chile

  • Investigational Site Number : 1520002, Santiago, Reg Metropolitana de Santiago, Chile

  • Investigational Site Number : 1520001, Santiago, Reg Metropolitana de Santiago, Chile

  • Investigational Site Number : 1520005, Viña del Mar, Valparaiso, Chile

  • Investigational Site Number : 2460004, Helsinki, Finland

  • Investigational Site Number : 2460003, Helsinki, Finland

  • Investigational Site Number : 2460002, Kuopio, Finland

  • Investigational Site Number : 2760004, Berlin, Germany

  • Investigational Site Number : 2760007, Frankfurt, Germany

  • Investigational Site Number : 2760008, Hamburg, Germany

  • Investigational Site Number : 2760009, Landsberg, Germany

  • Investigational Site Number : 2760002, Münster, Germany

  • Investigational Site Number : 2760001, Tübingen, Germany

  • Investigational Site Number : 2760005, Wiesbaden, Germany

  • Investigational Site Number : 2760003, Würzburg, Germany

  • Investigational Site Number : 3480002, Budapest, Hungary

  • Investigational Site Number : 3480004, Debrecen, Hungary

  • Investigational Site Number : 3480003, Nyíregyháza, Hungary

  • Investigational Site Number : 3480001, Pécs, Hungary

  • Investigational Site Number : 3760007, Haifa, Israel

  • Investigational Site Number : 3760004, Kefar Sava, Israel

  • Investigational Site Number : 3760005, Petah Tikva, Israel

  • Investigational Site Number : 3760009, Tel Aviv, Israel

  • Azienda Ospedaliero-Universitaria di Ferrara-Site Number: 3800004, Cona, Ferrara, Italy

  • Azienda Ospedaliera Universitaria Careggi-Site Number : 3800011, Florence, Firenze, Italy

  • IRCCS Ospedale Policlinico San Martino-Site Number : 3800013, Genoa, Genova, Italy

  • ASST Santi Paolo e Carlo-Presidio Ospedale San Paolo-Site Number : 3800006, Milan, Milano, Italy

  • Azienda Ospedale - Università Padova-Site Number : 3800008, Padua, Padova, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Site Number: 3800002, Rome, Roma, Italy

  • Ospedale Bellaria-Site Number: 3800009, Bologna, Italy

  • Investigational Site Number : 3920010, Ichikawa, Chiba, Japan

  • Investigational Site Number : 3920004, Narita, Chiba, Japan

  • Investigational Site Number : 3920009, Isehara, Kanagawa, Japan

  • Investigational Site Number : 3920002, Odawara, Kanagawa, Japan

  • Investigational Site Number : 3920014, Yokohama, Kanagawa, Japan

  • Investigational Site Number : 3920005, Suwa, Nagano, Japan

  • Investigational Site Number : 3920012, Kusatsu, Shiga, Japan

  • Investigational Site Number : 3920006, Fukui, Japan

  • Investigational Site Number : 3920001, Fukuoka, Japan

  • Investigational Site Number : 3920011, Hiroshima, Japan

  • Investigational Site Number : 3920003, Kumamoto, Japan

  • Investigational Site Number : 3920013, Niigata, Japan

  • Investigational Site Number : 3920008, Tokyo, Japan

  • Investigational Site Number : 4840004, Chihuahua City, Mexico

  • Investigational Site Number : 4840003, Durango, Mexico

  • Investigational Site Number : 5280004, Alkmaar, Netherlands

  • Investigational Site Number : 5280002, Leiderdorp, Netherlands

  • Investigational Site Number : 6160006, Krakow, Lesser Poland Voivodeship, Poland

  • Investigational Site Number : 6160001, Wroclaw, Lower Silesian Voivodeship, Poland

  • Investigational Site Number : 6160004, Wroclaw, Lower Silesian Voivodeship, Poland

  • Investigational Site Number : 6160005, Lublin, Lublin Voivodeship, Poland

  • Investigational Site Number : 6160002, Warsaw, Masovian Voivodeship, Poland

  • Investigational Site Number : 6160003, Bialystok, Podlaskie Voivodeship, Poland

  • Investigational Site Number : 6200003, Guimarães, Portugal

  • Investigational Site Number : 6200004, Matosinhos Municipality, Portugal

  • Investigational Site Number : 6200002, Porto, Portugal

  • Investigational Site Number : 6200001, Santa Maria da Feira, Portugal

  • Investigational Site Number : 4100005, Cheonan-Si, Chungcheongnam-do, South Korea

  • Investigational Site Number : 4100009, Seongnam-si, Gyeonggi-do, South Korea

  • Investigational Site Number : 4100008, Incheon, Incheon-gwangyeoksi, South Korea

  • Investigational Site Number : 4100003, Seoul, Seoul-teukbyeolsi, South Korea

  • Investigational Site Number : 4100004, Seoul, Seoul-teukbyeolsi, South Korea

  • Investigational Site Number : 4100002, Seoul, Seoul-teukbyeolsi, South Korea

  • Investigational Site Number : 4100001, Seoul, Seoul-teukbyeolsi, South Korea

  • Investigational Site Number : 4100006, Seoul, South Korea

  • Investigational Site Number : 7240007, Santiago de Compostela, A Coruña [La Coruña], Spain

  • Investigational Site Number : 7240003, Santiago de Compostela, A Coruña [La Coruña], Spain

  • Investigational Site Number : 7240008, Barcelona, Barcelona [Barcelona], Spain

  • Investigational Site Number : 7240002, Barcelona, Catalunya [Cataluña], Spain

  • Investigational Site Number : 7240004, Jerez de la Frontera, Cádiz, Spain

  • Investigational Site Number : 7240001, Majadahonda, Madrid, Spain

  • Investigational Site Number : 7240006, Seville, Sevilla, Spain

  • Investigational Site Number : 7240009, Sabadell, Spain

  • Investigational Site Number : 7240005, Zaragoza, Spain

  • Investigational Site Number : 7520002, Lund, Sweden

  • Investigational Site Number : 7520001, Solna, Sweden

  • Investigational Site Number : 7520004, Stockholm, Sweden

  • Investigational Site Number : 7920003, Ankara, Turkey (Türkiye)

  • Investigational Site Number : 7920001, Istanbul, Turkey (Türkiye)

  • Investigational Site Number : 7920002, Istanbul, Turkey (Türkiye)

  • Investigational Site Number : 8260002, London, London, City of, United Kingdom

  • Investigational Site Number : 8260006, Oxford, Oxfordshire, United Kingdom

  • Investigational Site Number : 8260004, Bradford, United Kingdom

  • Investigational Site Number : 8260001, Newcastle upon Tyne, United Kingdom

מובילי המחקר
  • Clinical Sciences & Operations

    Study Director

    Sanofi